170371 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details; Regulators; Modulating activity stimulating, promoting or activating activity
BRIGHTFIELD TRIPLEX IMMUNOHISTOCHEMISTRY ASSAY FOR EVALUATING THE COLOCALIZATION OF THE ER, PR, AND KI-67 BIOMARKERS IN CELLS
#2BIOMARKERS IN LONG-COVID-19
#3ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#4MONITORING INFLAMMATION STATUS
#5PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE
#6USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS
#7FAP DETECTION
#8IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER
#9Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning
#10PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF
#11GLYCOPROTEIN BIOMARKERS FOR DIAGNOSING CANCER
#12SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#13EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS
#14IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER
#15IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER
#16COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#17RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition
#18MATERIAL AND METHOD TO SCREEN PROTEASOME STIMULATORS
#19COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT
#20METHODS FOR MODULATING A SRC-1 CONDENSATE
#21KIDNEY FUNCTION BIOMARKERS
#22METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS
#23COMPOSITIONS AND METHODS FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS
#24METHODS AND COMPOSITIONS FOR TARGETING CYTOSOLIC DSDNA SIGNALING IN CHROMOSOMALLY UNSTABLE CANCERS
#25DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS
#26NORMAL-PRESSURE HYDROCEPHALUS DIAGNOSIS COMPOSITION AND DIAGNOSIS MARKER DETECTION METHOD, USING LEVEL OF EXPRESSION OF CHI3L1 IN BLOOD
#27METHOD FOR PREDICTION OF THE PROGRESSION RISK OF TUMORS
#28METHODS AND MATERIALS FOR TREATING CANCER
#29Use of MYOG gene as target in preparation of drug for treating cardiomyocyte apoptosis-associated cardiovascular disease
#30IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#31Biomarker for diagnosing rheumatoid arthritis and uses thereof
#32KMT2A-MAML2 FUSION MOLECULES AND USES THEREOF
#33SCREENING METHOD
#34BIOMARKER WITH THERAPEUTIC IMPLICATIONS FOR PERITONEAL CARCINOMATOSIS
#35METHOD FOR TREATING CANCER
#36Material and method to screen proteasome stimulators
#37MONOCLONAL ANTIBODIES BINDING MCM5
#38METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#39COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#40METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#41Method for the prognosis and treatment of cancer metastasis
#42ENHANCING ANTI-TUMOR RESPONSE IN MELANOMA CELLS WITH DEFECTIVE STING SIGNALING
#43Beta-catenin inhibitors in cancer immunotherapy
#44Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#45CANCER TREATMENT AND DIAGNOSIS
#46Method for predicting the risk of obesity in a subject
#47Methods and Compositions for Modulating TH-GM Cell Function
#48Evaluation, assays and treatment of pKal-mediated disorders
#49RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
#50Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
#51METHOD FOR PREDICTING THE RISK OF A SUBJECT FOR CONTRACTING DIABETES MELLITUS AND/OR METABOLIC SYNDROME OR FOR DIAGNOSING METABOLIC SYNDROME IN A SUBJECT
#52Method for treating and prognosing cancer
#53COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#54Screening method
#55METHODS AND COMPOSITIONS FOR PROVIDING PREECLAMPSIA ASSESSMENT
#56ELISA assay for measuring function of properdin and kits for conducting ELISA assays using anti-properdin antibodies
#57Cancer treatment and diagnosis
#58METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#59Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
#60Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)
#61Material and method to screen proteasome stimulators
#62Screening method
#63Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#64Sensitivity markers and uses for CDK7 inhibitors in breast cancers
#65Screening method
#66METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#67Method for predicting the risk of obesity in a subject
#68Method for treating and prognosing cancer
#69Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#70IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS
#71SecA INHIBITORS AND METHODS OF MAKING AND USING THEREOF
#72Assessing whether a subject shall be subjected to imaging based diagnostic
#73MONOCLONAL ANTIBODIES BINDING MCM5
#74CANCER TREATMENT AND DIAGNOSIS
#75Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#76KIDNEY FUNCTION BIOMARKERS
#77Autoantigens for diagnosis of rheumatoid arthritis
#78Detection of ovarian cancer using antibody arrays
#79Beta-catenin inhibitors in cancer immunotherapy
#80Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#81Screening method
#82Production of midbrain dopaminergic neurons and methods for the use thereof
#83Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#84Method for the prognosis and treatment of cancer metastasis
#85Compositions and methods for treating eye infections and disease
#86COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#87Biomarker FOXF2 for gastric cancer
#88Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A variant 2)
#89METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#90SCREENING METHOD
#91Screening method
#92Reactive oxygen species production by myeloid-derived suppressor cells as a predictor of patient response to interferon-α therapy
#93Methods and compositions for modulating T-GM cell function
#94Compositions and methods for treating eye infections and disease
#95METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING CANCER CELLS
#96Methods for identifying compounds as modulators of SLC38A9 interactions
#97Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays
#98Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#99METHOD FOR TREATING CANCER
#100Peptides derived from NCAPG2 and their use
#101In Vitro Method of Diagnosing Parkinson's Disease
#102STAT3 phosphorylation during graft-versus-host disease
#103AGENTS, METHODS AND KITS FOR TREATING AND DETECTING DIABETIC NEPHROPATHY AND PROLIFERATIVE DISEASES AND METHODS FOR INHIBITING EXPRESSION OF TYPE IV COLLAGEN
#104Methods for diagnosing osteoarthritis
#105Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof
#106MELANOMA CHEMOPREVENTION
#107HIGH-AFFINITY BINDING TO GAS6
#108Method for removing genomically unstable IPS cells and synthetic peptide used therefor
#109Methods and Compositions for Targeting Tumor Microenvironment and for preventing Metastasis
#110Methods and Devices for Detecting Kidney Damage
#111TREATING NEURODEGENERATIVE DISEASE WITH FENOFIBRATE AND ANALOGS THEREOF
#112Detection of ovarian cancer using antibody arrays
#113Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#114METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS
#115Methods for detecting and treating variants of seborrheic keratoses
#116Method of In Vitro Diagnosis of a Neurological Disorder
#117PROGNOSIS AND PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF
#118Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#119Lung cancer biomarker
#120METHOD FOR MONITORING METASTASIS OF CANCER CELLS USING CELLS CULTURED IN THREE DIMENSIONAL COLLAGEN ENVIRONMENT
#121Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#122Compositions and methods for inhibiting HMGB1 activation of melanocytes
#123Method of making a skin care composition
#124THE CHILDREN'S HOSPITAL OF PHILADELPHIA
#125BIOMARKERS FOR PREDICTING RESPONSE OF DLBCL TO TREATMENT WITH A BTK INHIBITOR
#126FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF
#127Assays for determining levels of plasma protease C1 inhibitor
#128METHODS OF TREATING PULMONARY FIBROSIS
#129Method for the prognosis and treatment of cancer metastasis
#130METHODS OF PROGNOSTICATING AND TREATING CANCER
#131Method for cell differentiation
#132Production of midbrain dopaminergic neurons and methods for the use thereof
#133Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#134PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER
#135Targets in multiple myeloma and other disorders
#136Body Fluid BIN1 as a Marker of Cardiac Health
#137DETECTION OF SUBJECT BIOMARKER DIAGNOSTIC ASSAY FOR DENGUE FEVER AND THE DIFFERENTIATION OF DENGUE HEMORRHAGIC FEVER
#138Biomarkers for the diagnosis and/or prognosis of clear cell renal cell carcinoma
#139Compositions and methods for detecting and treating colorectal cancer
#140METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES
#141Biomarkers for subtypes of cervical cancer
#142Method for determining sensitivity to decitabine treatment
#143Peptides derived from NCAPG2 and their use
#144IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#145Method of diagnosis and treatment
#146METHODS AND COMPOSITIONS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1alpha (PGC1alpha) AS A TARGET OF CIRCULATING TUMOR CELLS
#147Renal Cell Carcinoma Biomarkers and Uses Thereof
#148CANCER PROGNOSTIC ASSAYS
#149SecA inhibitors and methods of making and using thereof
#150Gene amplification of coactivator CoAA and uses thereof
#151METHOD FOR PREDICTION OF THE PROGRESSION RISK OF TUMORS
#152Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
#153Activation of myeloid-derived suppressor cells as a predictor of patient response to interferon-A therapy
#154Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject
#155METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#156Curaxins for use in treating carcinogen-induced cancer
#157KIDNEY FUNCTION BIOMARKERS
#158Screening method
#159Method for successful retrieval of sperm
#160Methods for assessing cancer recurrence
#161Method for screening for a cancer treatment agent using the interaction between PAUF and a binding partner thereof
#162Method for screening substance relating to endoplasmic reticulum stress participating in onset of diabetes
#163Use of a growth-stimulating protein
#164Renal Cell Carcinoma Biomarkers and Uses Thereof
#165SUMO as a marker of cancer development and target for cancer therapy
#166COMPOSITIONS AND METHODS FOR DETECTING NOONAN SYNDROME
#167METHODS OF MODULATING BINDING OF SON OF SEVENLESS TO PHOSPHATIDIC ACID AND IDENTIFYING COMPOUNDS THAT MODULATE SUCH BINDING
#168METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS
#169FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#170METHODS OF DIAGNOSIS AND TREATMENT OF MELANOMA
#171Use of a growth-stimulating protein
#172BLOOD TEST FOR THE DETECTION OF CANCER
#173Materials and methods for treatment of cancer and identification of anti-cancer compounds
#174Use of Pateamine A for the treatment of age-related muscle wasting
#175ATF4 inhibitors and their use for neural protection, repair, regeneration, and plasticity
#176Biomarkers for subtypes of cervical cancer
#177Method for prediction of the progression risk of tumors
#178Methods and Devices for Detecting Kidney Transplant Rejection
#179Use of Activating Transcription Factor-2 (ATF2) for Detecting Skin Cancer
#180Cell cycle regulation and differentiation
#181DETECTION OF ELEVATED LEVELS OF HER-2/NEU PROTEIN ON CIRCULATING CANCER CELLS AND TREATMENT
#182Devices for Detecting Renal Disorders
#183Methods and Devices for Detecting Kidney Damage
#184Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#185Computer Methods and Devices for Detecting Kidney Damage
#186Methods and devices for detecting obstructive uropathy and associated disorders
#187Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#188Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
#189COMPOSITION AND METHOD FOR DIAGNOSIS OR DETECTION OF RENAL CANCER
#190Methods for use with BAFF antagonists
#191NEURITE OUTGROWTH AS AN ASSAY FOR MEMORY ENHANCING COMPOUNDS
#192Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
#193DIAGNOSIS AND TREATMENT OF CERVICAL CANCER
#194Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1
#195VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use
#196METHODS FOR DIAGNOSING OSTEOARTHRITIS
#197Compositions and Methods for Modulating Osteoblast Cell Differentiation and Bone Generation Through HIF-1a
#198Compositions and methods for detecting Noonan syndrome
#199Screening method
#200Cell cycle regulation and differentiation
#201Use Of A Growth-Stimulating Protein
#202TORC POLYNUCLEOTIDES AND POLYPEPTIDES AND METHOD OF USE
#203METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES
#204Methods for predicting cardiac toxicity
#205METHODS OF MODULATING BINDING OF SON OF SEVENLESS TO PHOSPHATIDIC ACID AND IDENTIFYING COMPOUNDS THAT MODULATE SUCH BINDING
#206Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
#207STRATIFIN DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#208STEM CELL REGULATOR, COMPOSITIONS AND METHODS OF USE
#209Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
#210Stem Cells, Method For Their Purification, Identification, and Use
#211GENE AMPLIFICATION OF COACTIVATOR COAA AND USES THEREOF
#212Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
#213Diagnosis and treatment of cervical cancer
#214Method for detecting candidate alzheimer's disease drug
#215Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or α1 type IV collagen
#216Modulation of IL-2 production by T-bet
#217Diagnosis and treatment of cervical cancer
#218Slim compositions and methods of use thereof
#219Neuroprotective effects of atf6
#220Modulation of Th2 lineage commitment by T-bet
#221Purified Stat proteins and methods of purifying thereof
#222Maxs as modifiers of the axin pathway and methods of use
#223Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof
#224SPRR1A and axonal regeneration
#225Systems and methods for analyzing resource production